PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Autor principal: | Lubaba, Anikah |
---|---|
Otros Autores: | Fariha, Luluel Maknun |
Formato: | Tesis |
Lenguaje: | English |
Publicado: |
Brac University
2024
|
Materias: | |
Acceso en línea: | http://hdl.handle.net/10361/23252 |
Ejemplares similares
-
Effect of vitamin D, calcium and multiple micronutrients supplementation on lipid profile in pre-menopausal Bangladeshi garment factory workers with hypovitaminosis D
por: Islam, Md Zahirul, et al.
Publicado: (2017) -
Post Covid-19 health indications of Covid-19 patients
por: Khan, Tanzim
Publicado: (2022) -
Heart disease prediction using machine learning algorithms
por: Ali, Musfiq, et al.
Publicado: (2019) -
হার্ট, ব্লাড, ফুড /
por: কাসেম, এম এ -
Anti-inflammatory effect of Statins in reducing the exacerbation and mortality rates of COPD patients: a review study
por: Shomi, Iffat Ara
Publicado: (2019)